{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:59:14Z","timestamp":1791212354928,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:00:00Z","timestamp":1779580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002799","name":"Capital Medical University","doi-asserted-by":"publisher","award":["CCMU2024ZKYXZ004"],"award-info":[{"award-number":["CCMU2024ZKYXZ004"]}],"id":[{"id":"10.13039\/501100002799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20250484980"],"award-info":[{"award-number":["20250484980"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20230484295"],"award-info":[{"award-number":["20230484295"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108831","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T07:36:43Z","timestamp":1779781003000},"page":"108831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CTLA-4 and CD154 expression on peripheral T cells as diagnostic biomarkers for pulmonary tuberculosis"],"prefix":"10.1016","volume":"170","author":[{"given":"Weicong","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaicheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6803-9807","authenticated-orcid":false,"given":"Yu","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108831_bib0001","series-title":"Global tuberculosis report 2024","year":"2024"},{"issue":"6","key":"10.1016\/j.ijid.2026.108831_bib0002","first-page":"691","article-title":"Progress on diagnosis and treatment of latent tuberculosis infection","volume":"51","author":"Ying","year":"2022","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"issue":"6","key":"10.1016\/j.ijid.2026.108831_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004818","article-title":"Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study","volume":"4","author":"Virenfeldt","year":"2014","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.ijid.2026.108831_bib0004","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114088","article-title":"Diagnostic biomarkers for active tuberculosis: progress and challenges","volume":"14","author":"Nogueira","year":"2022","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.1016\/j.ijid.2026.108831_bib0005","doi-asserted-by":"crossref","first-page":"6568","DOI":"10.4081\/idr.2016.6568","article-title":"Tuberculosis biomarkers: from diagnosis to protection","volume":"8","author":"Goletti","year":"2016","journal-title":"Infect Dis Rep"},{"issue":"4","key":"10.1016\/j.ijid.2026.108831_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00875-1","article-title":"Clinical implications of molecular drug resistance testing for mycobacterium tuberculosis: a 2023 TBnet\/RESIST-TB consensus statement","volume":"23","author":"Dominguez","year":"2023","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2026.108831_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO\u2019s global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"issue":"2","key":"10.1016\/j.ijid.2026.108831_bib0008","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/13993003.00543-2016","article-title":"Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: what lessons have we learnt and how can we do better?","volume":"48","author":"Albert","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2026.108831_bib0009","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1093\/infdis\/jiz097","article-title":"Guidance for the evaluation of tuberculosis diagnostics that meet the World Health Organization (WHO) target product profiles: an introduction to WHO process and study design principles","volume":"220","author":"Denkinger","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2026.108831_bib0010","series-title":"Consensus meeting report: development of a target product profile (TPP) and a framework for evaluation for a test for predicting progression from tuberculosis infection to active disease","year":"2017"},{"key":"10.1016\/j.ijid.2026.108831_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.128038","article-title":"Assessing the risk of TB progression: advances in blood-based biomarker research","volume":"292","author":"Li","year":"2025","journal-title":"Microbiol Res"},{"issue":"3","key":"10.1016\/j.ijid.2026.108831_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030535","article-title":"Identification of Tregs-related genes with molecular patterns in patients with systemic sclerosis related to ILD","volume":"13","author":"Luo","year":"2023","journal-title":"Biomolecules"},{"issue":"7309","key":"10.1016\/j.ijid.2026.108831_bib0013","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09247","article-title":"An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis","volume":"466","author":"Berry","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijid.2026.108831_bib0014","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-021-02970-8","article-title":"Combined IFN-\u03b3 and IL-2 release assay for detect active pulmonary tuberculosis: a prospective multicentre diagnostic study in China","volume":"19","author":"Tan","year":"2021","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/j.ijid.2026.108831_bib0015","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/qjmed\/hcad214","article-title":"A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study","volume":"116","author":"Li","year":"2023","journal-title":"Qjm-Int J Med"},{"issue":"8","key":"10.1016\/j.ijid.2026.108831_bib0016","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173273","article-title":"Integrated plasma proteomics identifies tuberculosis-specific diagnostic biomarkers","volume":"9","author":"Schiff","year":"2024","journal-title":"Jci Insight"},{"issue":"18","key":"10.1016\/j.ijid.2026.108831_bib0017","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137427","article-title":"Comprehensive plasma proteomic profiling reveals biomarkers for active tuberculosis","volume":"5","author":"Garay-Baquero","year":"2020","journal-title":"Jci Insight"},{"issue":"1","key":"10.1016\/j.ijid.2026.108831_bib0018","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to mycobacterium tuberculosis in humans","volume":"264","author":"Jasenosky","year":"2015","journal-title":"Immunol Rev"},{"issue":"9","key":"10.1016\/j.ijid.2026.108831_bib0019","article-title":"Study of CD27 and CCR4 markers on specific CD4+T-cells as immune tools for active and latent tuberculosis management","volume":"9","author":"Latorre","year":"2019","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108831_bib0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/eji.201646583","article-title":"Local checkpoint inhibition of CTLA-4 as a monotherapy or in combination with anti-PD1 prevents the growth of murine bladder cancer","volume":"47","author":"van Hooren","year":"2017","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.ijid.2026.108831_bib0021","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.it.2014.12.001","article-title":"Confusing signals: recent progress in CTLA-4 biology","volume":"36","author":"Walker","year":"2015","journal-title":"Trends Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2026.108831_bib0022","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/eji.200939261","article-title":"CTLA-4 co-receptor impacts on the function of treg and CD8+ T-cell subsets","volume":"39","author":"Rudd","year":"2009","journal-title":"Eur J Immunol"},{"issue":"Sup63","key":"10.1016\/j.ijid.2026.108831_bib0023","first-page":"3","article-title":"The change of PD-1 and CTLA-4 during LTBI and TB reactivation","volume":"54","author":"Shu","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ijid.2026.108831_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11040567","article-title":"Immunophenotype of T cells expressing programmed death-1 and cytotoxic T cell antigen-4 in early lung cancer: local vs. systemic immune response","volume":"11","author":"Kwiecien","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.ijid.2026.108831_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/jcbr.2022.168536.1282","article-title":"Association of CTLA4 and PD-L1 immunohistchemical expression with various clinicopathological parameters and survival in non\u2013small-cell lung cancer","volume":"6","author":"Amer","year":"2022","journal-title":"Int J Cancer Biomed Res"},{"issue":"10","key":"10.1016\/j.ijid.2026.108831_bib0026","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/nm1292","article-title":"Direct access to CD4+ T cells specific for defined antigens according to CD154 expression","volume":"11","author":"Frentsch","year":"2005","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ijid.2026.108831_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01780-2021","article-title":"Mycobacterium tuberculosis-specific CD4 T-cell scoring discriminates tuberculosis infection from disease","volume":"60","author":"Mantei","year":"2022","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ijid.2026.108831_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2025.106449","article-title":"Clustering mycobacterium tuberculosis-specific CD154+CD4+T cells for distinguishing tuberculosis disease from infection based on single-cell RNA-seq analysis","volume":"90","author":"Wang","year":"2025","journal-title":"J Infection"},{"issue":"1","key":"10.1016\/j.ijid.2026.108831_bib0029","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12865-024-00652-w","article-title":"The diagnostic value and validation of IL-22 combimed with sCD40L in tuberculosis pleural effusion","volume":"25","author":"Xu","year":"2024","journal-title":"BMC Immunol"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226004662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:50:28Z","timestamp":1791211828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226004662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S1201971226004662"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108831","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CTLA-4 and CD154 expression on peripheral T cells as diagnostic biomarkers for pulmonary tuberculosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108831","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108831"}}